Palisade Bio (PALI) FCF Margin Growth (1y) (2012 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 4.12 Mn |
| Jun 30, 2020 | -611,393.00 |
| Mar 31, 2020 | 3.88 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Sep 30, 2019 | -933,128.00 |
| Jun 30, 2019 | -1.98 Mn |
| Mar 31, 2019 | 724,176.00 |
| Dec 31, 2018 | -6.54 Mn |
| Sep 30, 2018 | 6.64 Mn |
| Jun 30, 2018 | 13.39 Mn |
| Mar 31, 2018 | 10.36 Mn |
| Dec 31, 2017 | 4.57 Mn |
| Sep 30, 2017 | 4.61 Mn |
| Jun 30, 2017 | 1.14 Mn |
| Mar 31, 2017 | -3.73 Mn |
| Dec 31, 2016 | 11.12 Mn |
| Sep 30, 2016 | 4.26 Mn |
| Jun 30, 2016 | 4.92 Mn |
| Mar 31, 2016 | 2.22 Mn |
| Dec 31, 2015 | -8.25 Mn |
| Sep 30, 2015 | -15.90 Mn |
| Jun 30, 2015 | -14.65 Mn |
| Mar 31, 2015 | -9.46 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Sep 30, 2014 | 3.17 Mn |
| Jun 30, 2014 | 8.56 Mn |
| Mar 31, 2014 | -6.53 Mn |
| Dec 31, 2013 | 179,676.00 |
| Sep 30, 2013 | -9.34 Mn |
| Jun 30, 2013 | -13.14 Mn |
| Mar 31, 2013 | -110,867.00 |
| Dec 31, 2012 | -10.05 Mn |
| Sep 30, 2012 | 92,731.00 |